United Health Products Enters Material Definitive Agreement
Ticker: UEEC · Form: 8-K · Filed: Jun 25, 2024 · CIK: 1096938
| Field | Detail |
|---|---|
| Company | United Health Products, INC. (UEEC) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.25 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-actions
TL;DR
UHP just signed a big deal, details TBD.
AI Summary
United Health Products, Inc. entered into a material definitive agreement on June 20, 2024. The filing does not disclose specific details of the agreement or any associated dollar amounts, but it is classified under 'Entry into a Material Definitive Agreement' and 'Financial Statements and Exhibits'. The company is incorporated in Nevada and its fiscal year ends on December 31.
Why It Matters
This filing indicates a significant new agreement for United Health Products, Inc., which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — The lack of specific details regarding the material definitive agreement introduces uncertainty about its nature and potential impact.
Key Players & Entities
- United Health Products, Inc. (company) — Registrant
- June 20, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 000-27781 (filing_id) — Commission File Number
- 84-1517723 (tax_id) — IRS Employer Identification No.
FAQ
What is the nature of the material definitive agreement entered into by United Health Products, Inc. on June 20, 2024?
The filing does not specify the nature of the material definitive agreement, only that one was entered into on June 20, 2024.
Are there any financial terms or dollar amounts associated with this material definitive agreement?
The provided filing excerpt does not contain any specific dollar amounts or financial terms related to the agreement.
What is the primary business of United Health Products, Inc. based on its SIC code?
United Health Products, Inc. is classified under SIC code 3842, which pertains to Orthopedic, Prosthetic & Surgical Appliances & Supplies.
When is the fiscal year end for United Health Products, Inc.?
The fiscal year end for United Health Products, Inc. is December 31.
What were the previous names of United Health Products, Inc.?
United Health Products, Inc. was formerly known as United EcoEnergy Corp. (name change date 20060224) and MNS EAGLE EQUITY GROUP III INC (name change date 19991019).
Filing Stats: 746 words · 3 min read · ~2 pages · Grade level 12.1 · Accepted 2024-06-25 11:49:07
Key Financial Figures
- $0.25 — ell shares, subject to a floor price of $0.25 per share. The Second Amendment further
Filing Documents
- ueec_8k.htm (8-K) — 27KB
- ueec_ex101.htm (EX-10.1) — 7KB
- 0001477932-24-003854.txt ( ) — 147KB
- ueec-20240620.xsd (EX-101.SCH) — 6KB
- ueec-20240620_lab.xml (EX-101.LAB) — 13KB
- ueec-20240620_cal.xml (EX-101.CAL) — 1KB
- ueec-20240620_pre.xml (EX-101.PRE) — 8KB
- ueec-20240620_def.xml (EX-101.DEF) — 2KB
- ueec_8k_htm.xml (XML) — 3KB
01. Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement. As previously reported by United Health Products, Inc. (the "Company") in a Current Report on Form 8-K filed with the Securities and Exchange Commission on September 7, 2022, the Company entered into a Common Stock Purchase Agreement dated September 1, 2022 (the "CSPA") with White Lion Capital, LLC ("White Lion"). The Company later reported an amendment to the CSPA in a Current Report on Form 8-K filed with the Securities and Exchange Commission on January 31, 2023. On June 20, 2024, the Company and White Lion further amended the CSPA (the "Second Amendment") to provide that the purchase price to be paid by White Lion for shares of the Company's common stock pursuant to the CSPA equals the lower of: (i) 93% of the volume-weighted average price of the Company's common stock during a period of five consecutive trading days following the Company's exercise of its right to sell shares (or 95% of that volume-weighted average price if the Company's common stock is trading on a national exchange), or (ii) the closing price of the common stock on the day the Company exercises its right to sell shares, subject to a floor price of $0.25 per share. The Second Amendment further provides that if the Company issues a share price purchase notice at a time that the Company's common stock is trading below the floor price and White Lion waives the floor price condition, the purchase price to be paid by White Lion for such shares shall equal 90% multiplied by the lower of the (i) three lowest volume-weighted average price of the Company's common stock during a period of five consecutive trading days following the Company's exercise of its right to sell shares, or (ii) most recent closing price of the Company's common stock prior to White Lion's receipt of a share price purchase notice. Except as set forth in the Second Amendment, all other terms, conditions, and provisions of the CSPA, remain in full force and effect. The for
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1 Amendment No. 2 to Common Stock Purchase Agreement 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. United Health Products, Inc. Dated: June 25, 2024 By: /s/ Brian Thom Brian Thom Chief Executive Officer 3